Loading...
XHKG
3309
Market cap276mUSD
Jun 16, Last price  
1.78HKD
1D
0.56%
1Q
3.49%
IPO
-75.78%
Name

C-Mer Eye Care Holdings Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
1.14
EPS
—
Div Yield, %
—
Shrs. gr., 5y
2.85%
Rev. gr., 5y
27.13%
Revenues
1.91b
-0.56%
156,472,000198,851,000248,659,000311,228,000429,374,000576,209,000699,545,0001,112,577,0001,731,903,0001,923,964,0001,913,162,000
Net income
-135m
L
22,361,00038,357,00046,887,00040,127,00042,571,00041,435,000-6,246,00021,861,000-21,875,00061,998,000-135,163,000
CFO
0k
-100.00%
42,606,00050,545,00053,497,00065,483,99940,904,000140,555,000104,032,000148,414,000191,858,000361,154,0000
Dividend
Jun 27, 20250.02 HKD/sh

Profile

C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates eye and surgery centers, and satellite clinics that provide cataract and intraocular lens implant, refractive correction, corneal and external eye disease, glaucoma, vitreo-retinal disease, oculoplastic and orbital disease, and squint and pediatric ophthalmology services. It also sells vision aid and pharmaceutical products, as well as dental services. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Eye Care Holdings Limited is a subsidiary of C-MER Group Limited.
URL
https://cmereye.com/
IPO date
Jan 15, 2018
Employees
2,115
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,913,162
-0.56%
1,923,964
11.09%
1,731,903
55.67%
Cost of revenue
1,792,236
1,807,732
1,838,681
Unusual Expense (Income)
NOPBT
120,926
116,232
(106,778)
NOPBT Margin
6.32%
6.04%
Operating Taxes
32,093
37,934
34,998
Tax Rate
26.54%
32.64%
NOPAT
88,833
78,298
(141,776)
Net income
(135,163)
-318.01%
61,998
-383.42%
(21,875)
-200.06%
Dividends
Dividend yield
Proceeds from repurchase of equity
(58,294)
577,737
BB yield
1.35%
-9.56%
Debt
Debt current
139,101
116,533
149,335
Long-term debt
687,397
586,310
303,152
Deferred revenue
281,937
Other long-term liabilities
121,529
53,343
2,968
Net debt
51,196
(47,652)
(375,192)
Cash flow
Cash from operating activities
361,154
191,858
CAPEX
(115,485)
(91,227)
Cash from investing activities
(245,371)
(210,650)
Cash from financing activities
(242,877)
281,640
FCF
139,914
135,661
(136,873)
Balance
Cash
528,014
557,418
698,512
Long term investments
247,288
193,077
129,167
Excess cash
679,644
654,297
741,084
Stockholders' equity
1,889,911
350,393
295,036
Invested Capital
1,769,587
2,059,226
2,139,807
ROIC
4.64%
3.73%
ROCE
4.94%
4.69%
EV
Common stock shares outstanding
1,233,343
1,255,517
1,233,126
Price
2.01
-41.57%
3.44
-29.80%
4.90
-28.88%
Market cap
2,479,019
-42.60%
4,318,980
-28.52%
6,042,318
-23.79%
EV
2,667,449
4,418,800
5,799,304
EBITDA
120,926
337,222
116,903
EV/EBITDA
22.06
13.10
49.61
Interest
18,122
19,656
Interest/NOPBT
15.59%